ATH-1017
Athira Pharma
[]
athira gave two oral presentations at #aan2023 highlighting clinical data from the act-ad #clinicaltrial of fosgonimeton in #alzheimers disease, as well as preclinical data supporting its therapeutic potential for alzheimer s and #parkinsons. learn more: 
Restoring lives by advancing bold therapies for neuronal health, thoughtfully and urgently.